Overview

2/6/02


Click here to start


Table of Contents

Overview

Renal Transplantation: Present Status

Clinical Impact of Nephrotoxicity

Mechanism of Action

RAPAMUNE

mTOR Is a Critical Kinase in Cell Cycle Progression

Rationale for Proposed Indication

RAPAMUNE + CsA Studies 301 + 302 (Integrated Data)

RAPAMUNE as Primary Therapy in De Novo Renal Transplantation

Improved Renal Function in RAPAMUNE Group**

RAPAMUNE Does Not Impair Renal Function in Psoriatic Patients

RAPAMUNE and Renal Function in Clinical Trials

Author: Maureen Galie